Completed NA INTERVENTIONAL 2-arm NCT04475029

Methadone in Cystectomy Patients (METAMORF)

Clinical Effectiveness and Safety of Intraoperative Methadone in Patients

Sponsor: University of Aarhus

Conditions Bladder Cancer Neurologic Manifestations Neurologic Symptoms Pain Pain, Postoperative Pathologic Processes Postoperative Complications Side Effect of Drug Signs and Symptoms

Interventions Methadone Morphine

Updated 7 times since 2020 Last updated: Sep 11, 2023 Started: Jul 6, 2020 Primary completion: Aug 15, 2023 Completion: Aug 17, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bladder Cancer and Neurologic Manifestations, this trial is completed. The trial is conducted by University of Aarhus and has accumulated 7 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
May 2023 — Oct 2023 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Feb 2023 — May 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jan 2021 — Feb 2023 [monthly]

Recruiting NA
Aug 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark